Two different compounds (pictured above) were generated using zinc (left) and manganese (right). Whilst these two compounds ‘look’ very similar the zinc compound demonstrated excellent anti-cancer activity and selectivity towards a range of cancers in the laboratory whereas the manganese compound was comparatively much more toxic, meaning there was more anti-cancer activity at a lower concentration, with similar selectivity compared to current drugs tested.
A team of scientists at the University of Huddersfield has discovered chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types, and which have demonstrated unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells
ONE of the most challenging aspects of cancer treatment is the huge variety of different tumours that can occur with each one potentially requiring a different solution because unfortunately, one drug does NOT fit all. In addition, another major issue of many current drugs is their poor selectivity towards cancers resulting in problems such as normal tissue toxicity, severe side effects and the development of drug resistance.
Now, a team of scientists at the University of Huddersfield is researching how to combat these challenges by using “self-assembled” drugs and although the research is in its very early stages, they’ve already had a breakthrough.
The science behind self-assembly
Self-assembly is the ability to instruct chemical systems with specific information so in the correct environment they will spontaneously generate biologically active compounds. Using this process many different compounds can be rapidly and easily formed with each different self-assembled drug having different chemotherapy properties.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer.”
Professor Craig Rice
In an article published by the journal Nature Communications, the University’s Professor Roger Phillips, Dr Simon Allison and Professor Craig Rice demonstrate chemical systems that self-assemble into molecular capsules which are highly toxic towards human cancer cells of a range of different tumour types.
More importantly, they show unprecedented cancer selectivity in the laboratory that, in some cases, are many thousands of times more toxic to the cancer cells compared to healthy, normal cells.
Cancer therapy without severe side-effects
Eventually, if similar results are obtained in more complex testing systems including in patients, and once considered safe after careful testing, it could offer the possibility of being able to treat cancers without the severe side effects commonly associated with chemotherapy drugs.
“Anti-cancer drug discovery and development can be enormously time consuming and expensive with a particular drug only being effective against a relatively small number of cancers with specific shared properties,” explained Professor Rice who heads the University’s Department of Chemical Sciences and is also the Director of the Structural, Molecular and Dynamic Modelling Centre within the School of Applied Sciences.
“In the future, it may be possible to target many cancers through this approach with the correct drug ‘self-assembled’ in such a manner to be selective for a specific cancer,” said Professor Rice.
Targeting hard-to-treat cancers
The research could also pave the way in targeting hard-to-treat cancers for which commonly used chemotherapy drugs have little or no effect.
The published studies show the new potential drug can be assembled with either zinc, copper, or manganese, with the three metal ions imparting significantly different chemotherapeutic properties via different mechanisms dependent upon which metal ion is used.
“It is this which allows the generation of different chemical systems each of which may have specificity for different cancers,” he said.
Original Article: Cancer therapy breakthrough in vitro using self-assembled drugs
More from: University of Huddersfield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Self-assembled drugs
- Mental illness more common than most people think
As a means of raising public awareness of mental illness in the United States, several research organizations have assembled statistics, including the National Institute of Mental Health.. According ...
- NTU scientists develop revolutionary drug delivery system inspired by caterpillars
the process of self-assembly presents a cost-effective and environmentally friendly alternative to traditional methods of manufacturing nanostructures. This technique could pave the way for more ...
- Student Assembly Introduces Measures to Prevent Bias, Implement Date-Rape-Drug Test Kits Following Controversy
Resolution 75 calls for increasing transparency, implementing anti-bias training and allocating funding for date-rape kits.
- Will make Jalandhar drug-free
I was born and brought up and studied in Jalandhar and worked here. People have seen the BJP candidiate’s work. The Congress candidate came from 160 km away. He is a failed politician, who lost badly ...
- The Hidden-Pregnancy Experiment
We are increasingly trading our privacy for a sense of security. Becoming a parent showed me how tempting, and how dangerous, that exchange can be.
Go deeper with Google Headlines on:
Self-assembled drugs
[google_news title=”” keyword=”self-assembled drugs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Cancer therapy without severe side-effects
- As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight risks
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A doctor weighed in on the potential risks.
- I Had Cancer. My Treatment Was Eye-Opening About Addiction
I've had two different types of cancer in two years and in both instances, I was screened, diagnosed early, and ushered into care.
- AI Tool for Predicting Breast Cancer Radiotherapy Side Effects Advances Toward Validation Trial
After validating a machine-learning tool for predicting arm lymphedema, researchers want to explore its ability to gauge the risk of other side effects.
- Most BCG-Unresponsive Bladder Cancer Responds to TAR-200 Treatment
A new delivery system of gemcitabine called TAR-200 resulted in promising responses in patients with high-risk non–muscle-invasive bladder cancer (NMIBC) that was not responsive to Bacillus ...
- PET Scans May Identify Patients With Breast Cancer Who May Not Need Chemo
PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy.
Go deeper with Google Headlines on:
Cancer therapy without severe side-effects
[google_news title=”” keyword=”Cancer therapy without severe side-effects” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]